Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor - Kavanaugh, A; Mease, P J; Gomez-Reino, J J (Ann Rheum Dis, 2014)
et al.